♥

Astec LifeSciences Limited

ISIN : INE563J01010
NSE : ASTEC
BSE : 533138
Face Value : 10
Industry : Pesticides & Agrochemicals

EPS : -23.93
EPS (TTM) : -52.83
Price to Earning (P/E) : -28.22
Book Value : 188.13
Price to Bookvalue (P/B) : 3.59
Dividend Yield : 0 %
Return on Equity (ROE) : -11.90 %
Return on Capital Employed (ROCE) : -4.50 %

Astec LifeSciences share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	559.9 - 541.35 -3.3 %
Low / High	536.35 - 559.9 4.4 %
Trade Volume	3,772
52 Week Low / High	512.35 - 998.1 94.8 %

YOU MAY ALSO LIKE

CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Stock market course tutorial
Stock Market Investment Course explained in simple words.
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
Share Market basics for beginners
Share Market jargons in simple terms
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR ASTEC LIFESCIENCES LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1842.66	1997.47	1171.81	1269.72	1428.49	1107.89	507.94	1537.48	693.72	985.46
Total Income	1869.77	2037.33	1209.7	1295.47	1445.57	1117.68	517.04	1557.96	702.96	1005.45
Total Expenditure	1588.17	1664.68	1050.57	1215.72	1397.16	1142.12	691.26	1410.39	1156.28	1182.81
Other Income	27.1	39.86	37.89	25.75	17.09	9.79	9.09	20.47	9.24	19.99
Operating Profit	281.6	372.65	159.13	79.75	48.41	-24.44	-174.22	147.57	-453.32	-177.36
Interest	39.24	45.14	58.77	63.99	64.62	59.94	60.95	66.75	70.43	93.35
PBDT	242.36	327.51	100.36	15.76	-16.21	-84.38	-235.17	80.82	-523.75	-270.71
Depreciation	89.27	81.69	87.96	77.6	93.86	91.58	87.03	90.07	92.65	114.71
Profit Before Tax	153.09	245.82	12.4	-61.84	-110.07	-175.96	-322.2	-9.25	-616.4	-385.42
Tax	39.02	62.66	3.93	-12.09	-28.21	-41.81	-78.93	0.38	-219.24	0.08
Profit After Tax	114.07	183.16	8.47	-49.75	-81.86	-134.15	-243.27	-9.63	-397.16	-385.5
Net Profit	114.07	183.16	8.47	-49.75	-81.86	-134.15	-243.27	-9.63	-397.16	-385.5
Equity Capital	195.98	196.05	196.06	196.06	196.06	196.09	196.09	196.09	196.1	196.11
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	5.82	9.34	0.43	-2.54	-4.18	-6.85	-12.41	-0.5	-20.26	-19.66
Diluted Eps After Extraordinary Items	5.81	9.34	0.43	-2.54	-4.18	-6.85	-12.41	-0.5	-20.26	-19.66
Diluted Eps Before Extraordinary Items	5.81	9.34	0.43	-2.54	-4.18	-6.85	-12.41	-0.5	-20.26	-19.66

STANDALONE QUARTERLY RESULT FOR ASTEC LIFESCIENCES LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1842.66	1997.47	1171.81	1269.72	1428.49	1107.89	507.94	1537.48	693.72	985.46
Total Income	1869.73	2037.29	1209.62	1295.38	1445.46	1117.45	516.94	1557.8	702.8	1005.28
Total Expenditure	1588.14	1664.66	1050.54	1215.69	1397.13	1142.09	691.23	1410.38	1156.22	1182.78
Other Income	27.07	39.82	37.81	25.66	16.97	9.55	9	20.32	9.07	19.82
Operating Profit	281.59	372.63	159.08	79.69	48.33	-24.64	-174.29	147.42	-453.42	-177.5
Interest	39.3	45.21	58.84	64.05	64.67	59.98	61	66.8	70.46	93.37
PBDT	242.29	327.42	100.24	15.64	-16.34	-84.62	-235.29	80.62	-523.88	-270.87
Depreciation	89.42	81.84	88.11	77.75	94	91.73	87.18	90.22	92.8	114.86
Profit Before Tax	152.87	245.58	12.13	-62.11	-110.34	-176.35	-322.47	-9.6	-616.68	-385.73
Tax	38.97	62.61	3.86	-12.15	-28.28	-41.9	-79	0.29	-219.31
Profit After Tax	113.9	182.97	8.27	-49.96	-82.06	-134.45	-243.47	-9.89	-397.37	-385.73
Net Profit	113.9	182.97	8.27	-49.96	-82.06	-134.45	-243.47	-9.89	-397.37	-385.73
Equity Capital	195.98	196.05	196.06	196.06	196.06	196.09	196.09	196.09	196.1	196.11
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	5.81	9.33	0.42	-2.55	-4.19	-6.86	-12.42	-0.5	-20.26	-19.67
Diluted Eps After Extraordinary Items	5.81	9.33	0.42	-2.55	-4.19	-6.86	-12.42	-0.5	-20.26	-19.67
Diluted Eps Before Extraordinary Items	5.81	9.33	0.42	-2.55	-4.19	-6.86	-12.42	-0.5	-20.26	-19.67

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR ASTEC LIFESCIENCES LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	6765.66	6281.66	4581.81
Total Income	6870.34	6412.26	4638.25
Total Expenditure	5224.94	5519.12	4640.93
Other Income	104.68	130.6	56.44
Operating Profit	1645.4	893.14	-2.68
Interest	90.58	207.14	252.26
PBDT	1554.82	686	-254.94
Depreciation	343.56	336.52	362.53
Profit Before Tax	1211.26	349.48	-617.47
Tax	312.43	93.54	-148.57
Profit After Tax	898.83	255.94	-468.9
Net Profit	898.83	255.94	-468.9
Equity Capital	195.98	196.06	196.09
Face Value (IN RS)	10	10	10
Reserves	3768.98	3997.58	3496.78
Calculated EPS	45.85	13.04	-23.93
Diluted Eps After Extraordinary Items	45.85	13.04	-23.93
Diluted Eps Before Extraordinary Items	45.85	13.04	-23.93

STANDALONE ANNUAL RESULT FOR ASTEC LIFESCIENCES LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	6765.66	6281.66	4581.81
Total Income	6870.3	6412.02	4637.64
Total Expenditure	5224.83	5519.02	4640.83
Other Income	104.63	130.36	55.84
Operating Profit	1645.47	893	-3.19
Interest	90.9	207.4	252.44
PBDT	1554.57	685.6	-255.63
Depreciation	344.16	337.12	363.13
Profit Before Tax	1210.41	348.48	-618.76
Tax	312.23	93.29	-148.89
Profit After Tax	898.18	255.19	-469.87
Net Profit	898.18	255.19	-469.87
Equity Capital	195.98	196.06	196.09
Face Value (IN RS)	10	10	10
Reserves	3763.83	3991.88	3490.67
Calculated EPS	45.83	13.02	-23.96
Diluted Eps After Extraordinary Items	45.83	13.02	-23.96
Diluted Eps Before Extraordinary Items	45.83	13.02	-23.96

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	558.79 Cr	679.83 Cr	631.23 Cr	459.26 Cr
Sales	558.79 Cr	679.83 Cr	631.23 Cr	458.78 Cr
Net Sales	554.87 Cr	676.57 Cr	628.17 Cr	458.18 Cr
Increase/Decrease in Stock	-2.55 Cr	-58 Cr	-59.59 Cr	45.7 Lk
Raw Material Consumed	344.6 Cr	444.82 Cr	460.83 Cr	318.82 Cr
Opening Raw Materials	75.84 Cr	57.87 Cr	80.44 Cr	128.05 Cr
Purchases Raw Materials	326.62 Cr	467.39 Cr	508.45 Cr	219.96 Cr
Closing Raw Materials	57.87 Cr	80.44 Cr	128.05 Cr	29.19 Cr
Power & Fuel Cost	25.28 Cr	38.04 Cr	45.68 Cr	35.87 Cr
Electricity & Power	25.28 Cr	38.04 Cr	45.68 Cr	35.87 Cr
Employee Cost	38.35 Cr	50.31 Cr	52.26 Cr	61.74 Cr
Salaries, Wages & Bonus	35.53 Cr	46.72 Cr	48.11 Cr	54.77 Cr
Contributions to EPF & Pension Funds	1.98 Cr	2.02 Cr	2.55 Cr	2.91 Cr
Workmen and Staff Welfare Expenses	82.34 Lk	1.48 Cr	1.27 Cr	3.77 Cr
Other Manufacturing Expenses	12.62 Cr	14.29 Cr	17.95 Cr	18.51 Cr
Repairs and Maintenance	3.64 Cr	5.19 Cr	5.64 Cr	5.6 Cr
General and Administration Expenses	9.95 Cr	11.8 Cr	16.77 Cr	15.65 Cr
Rent , Rates & Taxes	1.62 Cr	1.62 Cr	1.72 Cr	4.27 Cr
Insurance	3.55 Cr	5.03 Cr	6.45 Cr	3.78 Cr
Professional and legal fees	2.85 Cr	2.9 Cr	5.58 Cr	3.11 Cr
Traveling and conveyance	22.36 Lk	35.77 Lk	79.91 Lk	1.59 Cr
Selling and Distribution Expenses	6.3 Cr	10.83 Cr	7.51 Cr	2.63 Cr
Freight and Forwarding	6.3 Cr	10.83 Cr	7.51 Cr	2.63 Cr
Miscellaneous Expenses	8.87 Cr	10.65 Cr	10.5 Cr	10.42 Cr
Bad debts /advances written off	10.56 Lk	25.14 Lk	1.98 Lk	0
Provision for doubtful debts	0	0	0	5.83 Lk
Loss on disposal of fixed assets(net)	1.67 Lk	0	52.35 Lk	11.14 Lk
Total Expenditure	443.42 Cr	522.74 Cr	551.91 Cr	464.09 Cr
Other Income	8.03 Cr	10.72 Cr	13.06 Cr	5.64 Cr
Interest Received	78.48 Lk	26.31 Lk	4.05 Cr	15.12 Lk
Profit on sale of Fixed Assets	0	1.43 Lk	0	0
Profits on sale of Investments	25.06 Lk	0	7.11 Lk	0
Provision Written Back	0	28.38 Lk	0	0
Foreign Exchange Gains	3.04 Cr	7.25 Cr	8.39 Cr	4.97 Cr
Operating Profit	119.48 Cr	164.54 Cr	89.31 Cr	-26.87 Lk
Interest	4.75 Cr	9.06 Cr	20.71 Cr	25.23 Cr
Interest on Term Loan	4.27 Cr	8.69 Cr	20.16 Cr	24.86 Cr
Bank Charges etc	48.07 Lk	36.28 Lk	55.6 Lk	36.95 Lk
PBDT	114.73 Cr	155.48 Cr	68.6 Cr	-25.49 Cr
Depreciation	25.66 Cr	34.36 Cr	33.65 Cr	36.25 Cr
Profit Before Taxation & Exceptional Items	89.07 Cr	121.13 Cr	34.95 Cr	-61.75 Cr
Profit Before Tax	89.07 Cr	121.13 Cr	34.95 Cr	-61.75 Cr
Provision for Tax	24 Cr	31.24 Cr	9.35 Cr	-14.86 Cr
Current Income Tax	23.26 Cr	28.63 Cr	2.67 Lk	3.66 Lk
Deferred Tax	-60.99 Lk	2.61 Cr	9.33 Cr	-14.89 Cr
Profit After Tax	65.07 Cr	89.88 Cr	25.59 Cr	-46.89 Cr
Minority Interest	-1.99 Lk	-2.4 Lk	-2.9 Lk	-3.85 Lk
Consolidated Net Profit	65.05 Cr	89.86 Cr	25.56 Cr	-46.93 Cr
Profit Balance B/F	154.9 Cr	216.84 Cr	303.75 Cr	326.15 Cr
Appropriations	219.95 Cr	306.69 Cr	329.32 Cr	279.22 Cr
Other Appropriation	3.11 Cr	2.94 Cr	3.17 Cr	3.51 Cr
Equity Dividend %	15	15	15	0
Earnings Per Share	33.21	45.85	13.04	-23.93
Adjusted EPS	33.21	45.85	13.04	-23.93

STANDALONE PROFIT / LOSS FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	558.79 Cr	679.83 Cr	631.23 Cr	459.26 Cr
Sales	558.79 Cr	679.83 Cr	631.23 Cr	458.78 Cr
Net Sales	554.87 Cr	676.57 Cr	628.17 Cr	458.18 Cr
Increase/Decrease in Stock	-2.55 Cr	-58 Cr	-59.59 Cr	45.7 Lk
Raw Material Consumed	344.6 Cr	444.82 Cr	460.84 Cr	318.82 Cr
Opening Raw Materials	75.84 Cr	57.87 Cr	80.44 Cr	128.05 Cr
Purchases Raw Materials	326.62 Cr	467.39 Cr	508.45 Cr	219.96 Cr
Closing Raw Materials	57.87 Cr	80.44 Cr	128.05 Cr	29.19 Cr
Power & Fuel Cost	25.28 Cr	38.04 Cr	45.68 Cr	35.87 Cr
Electricity & Power	25.28 Cr	38.04 Cr	45.68 Cr	35.87 Cr
Employee Cost	38.35 Cr	50.31 Cr	52.26 Cr	61.74 Cr
Salaries, Wages & Bonus	35.53 Cr	46.72 Cr	48.11 Cr	54.77 Cr
Contributions to EPF & Pension Funds	1.98 Cr	2.02 Cr	2.55 Cr	2.91 Cr
Workmen and Staff Welfare Expenses	82.34 Lk	1.48 Cr	1.27 Cr	3.77 Cr
Other Manufacturing Expenses	12.62 Cr	14.29 Cr	17.95 Cr	18.51 Cr
Repairs and Maintenance	3.64 Cr	5.19 Cr	5.64 Cr	5.6 Cr
General and Administration Expenses	9.94 Cr	11.79 Cr	16.76 Cr	15.64 Cr
Rent , Rates & Taxes	1.61 Cr	1.62 Cr	1.71 Cr	4.27 Cr
Insurance	3.55 Cr	5.03 Cr	6.45 Cr	3.78 Cr
Professional and legal fees	2.84 Cr	2.9 Cr	5.58 Cr	3.11 Cr
Traveling and conveyance	22.36 Lk	35.77 Lk	79.91 Lk	1.59 Cr
Selling and Distribution Expenses	6.3 Cr	10.83 Cr	7.51 Cr	2.63 Cr
Freight and Forwarding	6.3 Cr	10.83 Cr	7.51 Cr	2.63 Cr
Miscellaneous Expenses	8.93 Cr	10.65 Cr	10.5 Cr	10.42 Cr
Bad debts /advances written off	10.56 Lk	25.14 Lk	1.98 Lk	0
Provision for doubtful debts	0	0	0	5.83 Lk
Loss on disposal of fixed assets(net)	1.67 Lk	0	52.35 Lk	11.14 Lk
Loss on sale of non-trade current investments	5.71 Lk	0	0	0
Total Expenditure	443.47 Cr	522.73 Cr	551.9 Cr	464.08 Cr
Other Income	7.78 Cr	10.71 Cr	13.04 Cr	5.58 Cr
Interest Received	78.48 Lk	25.87 Lk	4.03 Cr	9.09 Lk
Profit on sale of Fixed Assets	0	1.43 Lk	0	0
Provision Written Back	0	28.38 Lk	7.11 Lk	0
Foreign Exchange Gains	3.04 Cr	7.25 Cr	8.39 Cr	4.97 Cr
Operating Profit	119.18 Cr	164.55 Cr	89.3 Cr	-31.91 Lk
Interest	4.79 Cr	9.09 Cr	20.74 Cr	25.24 Cr
Interest on Term Loan	4.31 Cr	8.73 Cr	20.18 Cr	24.87 Cr
Bank Charges etc	48.07 Lk	36.28 Lk	55.6 Lk	36.95 Lk
PBDT	114.39 Cr	155.46 Cr	68.56 Cr	-25.56 Cr
Depreciation	25.71 Cr	34.42 Cr	33.71 Cr	36.31 Cr
Profit Before Taxation & Exceptional Items	88.67 Cr	121.04 Cr	34.85 Cr	-61.88 Cr
Profit Before Tax	88.67 Cr	121.04 Cr	34.85 Cr	-61.88 Cr
Provision for Tax	23.98 Cr	31.22 Cr	9.33 Cr	-14.89 Cr
Current Income Tax	23.24 Cr	28.61 Cr	0	0
Deferred Tax	-61.24 Lk	2.61 Cr	9.33 Cr	-14.89 Cr
Profit After Tax	64.69 Cr	89.82 Cr	25.52 Cr	-46.99 Cr
Consolidated Net Profit	64.69 Cr	89.82 Cr	25.52 Cr	-46.99 Cr
Profit Balance B/F	154.79 Cr	216.37 Cr	303.25 Cr	325.6 Cr
Appropriations	219.48 Cr	306.19 Cr	328.77 Cr	278.61 Cr
Other Appropriation	3.11 Cr	2.94 Cr	3.17 Cr	3.51 Cr
Equity Dividend %	15	15	15	0
Earnings Per Share	33.03	45.83	13.02	-23.96
Adjusted EPS	33.03	45.83	13.02	-23.96

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR ASTEC LIFESCIENCES LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	89.07 Cr	121.13 Cr	34.95 Cr	-61.75 Cr
Adjustment	29.1 Cr	41.73 Cr	50.51 Cr	63.44 Cr
Changes In working Capital	-103.32 Cr	-110.1 Cr	-5.91 Cr	10.49 Cr
Cash Flow after changes in Working Capital	14.85 Cr	52.75 Cr	79.55 Cr	12.19 Cr
Cash Flow from Operating Activities	-8.16 Cr	23.6 Cr	74.66 Cr	10.22 Cr
Cash Flow from Investing Activities	-73.11 Cr	-103.87 Cr	-112.51 Cr	-135.18 Cr
Cash Flow from Financing Activitie	81.34 Cr	80.48 Cr	37.77 Cr	124.96 Cr
Net Cash Inflow / Outflow	6.44 Lk	21.57 Lk	-8.11 Lk	-19,000
Opening Cash & Cash Equivalents	30.81 Lk	33.88 Lk	55.45 Lk	47.34 Lk
Cash & Cash Equivalent of Subsidiaries under liquidations	-3.37 Lk	0	0	0
Closing Cash & Cash Equivalent	33.88 Lk	55.45 Lk	47.34 Lk	47.15 Lk

STANDALONE CASH FLOW FOR ASTEC LIFESCIENCES LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	88.67 Cr	121.04 Cr	34.85 Cr	-61.88 Cr
Adjustment	29.52 Cr	41.83 Cr	50.61 Cr	63.58 Cr
Changes In working Capital	-103.26 Cr	-110.33 Cr	-6.28 Cr	10.36 Cr
Cash Flow after changes in Working Capital	14.93 Cr	52.54 Cr	79.18 Cr	12.06 Cr
Cash Flow from Operating Activities	-8.06 Cr	23.41 Cr	74.32 Cr	10.13 Cr
Cash Flow from Investing Activities	-73.11 Cr	-103.57 Cr	-112.07 Cr	-134.98 Cr
Cash Flow from Financing Activitie	81.23 Cr	80.37 Cr	37.66 Cr	124.85 Cr
Net Cash Inflow / Outflow	5.68 Lk	21.52 Lk	-8.81 Lk	40,000
Opening Cash & Cash Equivalents	27.26 Lk	32.94 Lk	54.46 Lk	45.65 Lk
Closing Cash & Cash Equivalent	32.94 Lk	54.46 Lk	45.65 Lk	46.05 Lk

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Equity - Authorised	25 Cr	25 Cr	25 Cr	25 Cr
Equity - Issued	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Equity Paid Up	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Face Value	10	10	10	10
Total Reserves	289.18 Cr	376.61 Cr	399.4 Cr	349.3 Cr
Securities Premium	59.83 Cr	60.35 Cr	60.74 Cr	61.09 Cr
Profit & Loss Account Balance	216.84 Cr	303.75 Cr	326.15 Cr	275.71 Cr
General Reserves	12.49 Cr	12.49 Cr	12.49 Cr	12.49 Cr
Reserve excluding Revaluation Reserve	289.18 Cr	376.61 Cr	399.4 Cr	349.3 Cr
Shareholder's Funds	309.18 Cr	396.5 Cr	419.36 Cr	369.29 Cr
Minority Interest	13.92 Lk	16.32 Lk	19.21 Lk	23.06 Lk
Unsecured Loans	40 Cr	0	10.86 Cr	199 Cr
Inter Corporate Deposits (Unsecured)	0	0	0	50 Cr
Loans - Banks	40 Cr	0	10.86 Cr	100 Cr
Deferred Tax Assets / Liabilities	5.47 Cr	8.08 Cr	20.97 Cr	6.76 Cr
Deferred Tax Assets	80.26 Lk	-8.08 Cr	10.86 Cr	28.75 Cr
Deferred Tax Liability	6.28 Cr	0	31.82 Cr	35.51 Cr
Other Long Term Liabilities	0	1 Cr	1.35 Cr	2.05 Cr
Long Term Provisions	51.72 Lk	42.77 Lk	50.49 Lk	47.82 Lk
Total Non-Current Liabilities	45.99 Cr	9.51 Cr	33.69 Cr	208.29 Cr
Trade Payables	124.82 Cr	189.83 Cr	177.18 Cr	89.28 Cr
Sundry Creditors	124.82 Cr	189.83 Cr	177.18 Cr	89.28 Cr
Other Current Liabilities	49.8 Cr	60.96 Cr	62.99 Cr	23.56 Cr
Advances received from customers	11.2 Lk	5.36 Cr	2.07 Cr	3.34 Lk
Short Term Borrowings	147.03 Cr	239.37 Cr	285.28 Cr	282.96 Cr
Secured ST Loans repayable on Demands	18 Cr	19.19 Cr	0	0
Working Capital Loans- Sec	18 Cr	19.19 Cr	0	0
Buyers Credits - Unsec	0	0	21.96 Cr	0
Short Term Provisions	63.43 Lk	43.18 Lk	74.99 Lk	1.36 Cr
Total Current Liabilities	322.28 Cr	490.59 Cr	526.2 Cr	397.16 Cr
Total Liabilities	677.59 Cr	896.76 Cr	979.44 Cr	974.96 Cr
Gross Block	315.53 Cr	477.12 Cr	488.06 Cr	592.35 Cr
Less: Accumulated Depreciation	102.86 Cr	137.18 Cr	169.58 Cr	206.39 Cr
Net Block	212.68 Cr	339.94 Cr	318.47 Cr	385.96 Cr
Capital Work in Progress	111.68 Cr	13.73 Cr	112.38 Cr	148.46 Cr
Non Current Investments	53,000	53,000	53,000	53,000
Long Term Investment	53,000	53,000	53,000	53,000
Unquoted	53,000	53,000	53,000	53,000
Long Term Loans & Advances	18.76 Cr	18.3 Cr	35.51 Cr	25.47 Cr
Total Non-Current Assets	347.16 Cr	381.08 Cr	480.59 Cr	576.47 Cr
Unquoted	53,000	53,000	53,000	53,000
Inventories	106.09 Cr	186.95 Cr	294.85 Cr	195.85 Cr
Raw Materials	57.87 Cr	80.44 Cr	128.05 Cr	29.19 Cr
Work-in Progress	37.92 Cr	58.31 Cr	61.55 Cr	50.22 Cr
Finished Goods	7.28 Cr	44.89 Cr	101.24 Cr	112.12 Cr
Stores and Spare	3.03 Cr	3.3 Cr	4 Cr	4.32 Cr
Sundry Debtors	187.15 Cr	273.63 Cr	154.9 Cr	169 Cr
Debtors more than Six months	0	94.07 Lk	2.7 Cr	28.24 Lk
Debtors Others	187.4 Cr	272.69 Cr	152.22 Cr	168.8 Cr
Cash and Bank	1.57 Cr	2.13 Cr	2.16 Cr	2.43 Cr
Cash in hand	74,000	15,000	13,000	16,000
Balances at Bank	1.57 Cr	2.13 Cr	2.16 Cr	2.43 Cr
Other Current Assets	4.22 Cr	9.85 Cr	5.37 Cr	6.76 Cr
Interest accrued on Investments	25.36 Lk	18.84 Lk	15.24 Lk	7 Lk
Prepaid Expenses	2.75 Cr	4.87 Cr	4.97 Cr	5.01 Cr
Short Term Loans and Advances	31.39 Cr	43.13 Cr	41.58 Cr	24.45 Cr
Advances recoverable in cash or in kind	1.08 Cr	4.2 Cr	1.22 Cr	1.32 Cr
Total Current Assets	330.43 Cr	515.68 Cr	498.85 Cr	398.49 Cr
Net Current Assets (Including Current Investments)	8.15 Cr	25.09 Cr	-27.35 Cr	1.33 Cr
Total Assets	677.59 Cr	896.76 Cr	979.44 Cr	974.96 Cr
Contingent Liabilities	211.56 Cr	244.44 Cr	202.89 Cr	212.48 Cr
Total Debt	187.2 Cr	279.37 Cr	341.18 Cr	493.9 Cr
Book Value	157.63	0	0	188.13
Adjusted Book Value	157.63	0	213.72	188.13

STANDALONE BALANCE SHEET FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Equity - Authorised	25 Cr	25 Cr	25 Cr	25 Cr
Equity - Issued	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Equity Paid Up	19.59 Cr	19.6 Cr	19.61 Cr	19.61 Cr
Face Value	10	10	10	10
Total Reserves	288.7 Cr	376.09 Cr	398.83 Cr	348.69 Cr
Securities Premium	59.83 Cr	60.35 Cr	60.74 Cr	61.09 Cr
Profit & Loss Account Balance	216.37 Cr	303.25 Cr	325.6 Cr	275.1 Cr
General Reserves	12.49 Cr	12.49 Cr	12.49 Cr	12.49 Cr
Reserve excluding Revaluation Reserve	288.7 Cr	376.09 Cr	398.83 Cr	348.69 Cr
Shareholder's Funds	308.7 Cr	395.98 Cr	418.79 Cr	368.68 Cr
Unsecured Loans	40 Cr	0	10.86 Cr	199 Cr
Inter Corporate Deposits (Unsecured)	0	0	0	50 Cr
Loans - Banks	40 Cr	0	10.86 Cr	100 Cr
Deferred Tax Assets / Liabilities	5.42 Cr	8.03 Cr	20.92 Cr	6.72 Cr
Deferred Tax Assets	82.21 Lk	-8.03 Cr	10.87 Cr	28.76 Cr
Deferred Tax Liability	6.25 Cr	0	31.79 Cr	35.47 Cr
Other Long Term Liabilities	28.61 Lk	1.2 Cr	1.46 Cr	2.07 Cr
Long Term Provisions	51.72 Lk	42.77 Lk	47.82 Lk	44.16 Lk
Total Non-Current Liabilities	46.23 Cr	9.66 Cr	33.72 Cr	208.22 Cr
Trade Payables	125.46 Cr	190.24 Cr	177.25 Cr	89.29 Cr
Sundry Creditors	125.46 Cr	190.24 Cr	177.25 Cr	89.29 Cr
Other Current Liabilities	49.85 Cr	61.02 Cr	63.05 Cr	23.64 Cr
Advances received from customers	11.2 Lk	5.36 Cr	2.07 Cr	3.34 Lk
Short Term Borrowings	147.03 Cr	239.37 Cr	285.28 Cr	282.96 Cr
Secured ST Loans repayable on Demands	18 Cr	19.19 Cr	0	0
Working Capital Loans- Sec	18 Cr	19.19 Cr	0	0
Buyers Credits - Unsec	0	0	21.96 Cr	0
Short Term Provisions	63.43 Lk	43.18 Lk	75 Lk	1.36 Cr
Total Current Liabilities	322.97 Cr	491.07 Cr	526.33 Cr	397.24 Cr
Total Liabilities	677.9 Cr	896.71 Cr	978.85 Cr	974.14 Cr
Gross Block	315.62 Cr	477.2 Cr	488.14 Cr	592.43 Cr
Less: Accumulated Depreciation	102.94 Cr	137.32 Cr	169.79 Cr	206.65 Cr
Net Block	212.67 Cr	339.88 Cr	318.35 Cr	385.78 Cr
Capital Work in Progress	111.68 Cr	13.73 Cr	112.38 Cr	148.46 Cr
Non Current Investments	42.71 Lk	42.71 Lk	42.71 Lk	42.71 Lk
Long Term Investment	42.71 Lk	42.71 Lk	42.71 Lk	42.71 Lk
Unquoted	43.71 Lk	43.71 Lk	43.71 Lk	43.71 Lk
Long Term Loans & Advances	18.66 Cr	18.2 Cr	35.37 Cr	25.42 Cr
Total Non-Current Assets	347.47 Cr	381.33 Cr	480.75 Cr	576.67 Cr
Unquoted	43.71 Lk	43.71 Lk	43.71 Lk	43.71 Lk
Inventories	106.09 Cr	186.95 Cr	294.85 Cr	195.85 Cr
Raw Materials	57.87 Cr	80.44 Cr	128.05 Cr	29.19 Cr
Work-in Progress	37.92 Cr	58.31 Cr	61.55 Cr	50.22 Cr
Finished Goods	7.28 Cr	44.89 Cr	101.24 Cr	112.12 Cr
Stores and Spare	3.03 Cr	3.3 Cr	4 Cr	4.32 Cr
Sundry Debtors	187.15 Cr	273.63 Cr	154.9 Cr	169 Cr
Debtors more than Six months	0	94.07 Lk	2.7 Cr	28.24 Lk
Debtors Others	187.4 Cr	272.69 Cr	152.22 Cr	168.8 Cr
Cash and Bank	1.56 Cr	1.81 Cr	1.38 Cr	1.39 Cr
Cash in hand	59,000	0	0	0
Balances at Bank	1.56 Cr	1.81 Cr	1.38 Cr	1.39 Cr
Other Current Assets	4.19 Cr	9.83 Cr	5.36 Cr	6.75 Cr
Interest accrued on Investments	25.36 Lk	18.84 Lk	15.24 Lk	7 Lk
Prepaid Expenses	2.73 Cr	4.85 Cr	4.96 Cr	5 Cr
Short Term Loans and Advances	31.43 Cr	43.16 Cr	41.61 Cr	24.48 Cr
Advances recoverable in cash or in kind	1.11 Cr	4.23 Cr	1.25 Cr	1.35 Cr
Total Current Assets	330.43 Cr	515.38 Cr	498.09 Cr	397.48 Cr
Net Current Assets (Including Current Investments)	7.46 Cr	24.31 Cr	-28.23 Cr	23.18 Lk
Total Assets	677.9 Cr	896.71 Cr	978.85 Cr	974.14 Cr
Contingent Liabilities	211.53 Cr	244.41 Cr	202.86 Cr	212.44 Cr
Total Debt	187.28 Cr	279.37 Cr	341.18 Cr	493.9 Cr
Book Value	157.39	0	0	187.82
Adjusted Book Value	157.39	0	213.43	187.82

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	33.21	45.85	13.04	-23.93
CEPS(Rs)	46.32	63.4	30.22	-5.42
DPS(Rs)	1.5	1.5	1.5	0
Book NAV/Share(Rs)	157.63	202.17	213.72	188.13
Tax Rate(%)	26.95	25.79	26.76	24.06
Margin Ratios
Core EBITDA Margin(%)	19.95	22.63	12.08	-1.29
EBIT Margin(%)	16.79	19.15	8.82	-7.95
Pre Tax Margin(%)	15.94	17.82	5.54	-13.45
PAT Margin (%)	11.64	13.22	4.05	-10.21
Cash Profit Margin (%)	16.24	18.28	9.39	-2.32
Performance Ratios
ROA(%)	10.42	11.42	2.69	-4.8
ROE(%)	23.46	25.5	6.28	-11.9
ROCE(%)	22.29	22.21	7.75	-4.5
Asset Turnover(x)	0.89	0.86	0.66	0.47
Sales/Fixed Asset(x)	1.91	1.72	1.31	0.85
Working Capital/Sales(x)	68.53	27.1	-23.08	344.64
Efficiency Ratios
Fixed Capital/Sales(x)	0.52	0.58	0.76	1.18
Receivable days	113.66	123.7	123.9	128.71
Inventory Days	74.22	78.67	139.3	194.99
Payable days	133.28	150.04	166.93	152.31
Valuation Parameters
PER(x)	30.12	38.22	106.02	0
PCE(x)	21.6	27.64	45.75	-195.78
Price/Book(x)	6.35	8.67	6.47	5.65
Yield(%)	0.15	0.09	0.11	0
EV/Net Sales(x)	3.87	5.49	4.85	5.62
EV/Core EBITDA(x)	17.95	22.56	34.14	-9579.67
EV/EBIT(x)	22.86	28.51	54.78	-70.48
EV/CE(x)	3.17	4.14	3.11	2.98
M Cap / Sales	3.53	5.08	4.31	4.55
Growth Ratio
Net Sales Growth(%)	6.17	21.93	-7.15	-27.06
Core EBITDA Growth(%)	23.03	37.72	-45.72	-100.3
EBIT Growth(%)	26.88	38.76	-57.24	-165.62
PAT Growth(%)	36.91	38.13	-71.53	-283.21
EPS Growth(%)	36.78	38.07	-71.56	-283.54
Financial Stability Ratios
Total Debt/Equity(x)	0.61	0.71	0.81	1.34
Current Ratio(x)	1.03	1.05	0.95	1
Quick Ratio(x)	0.7	0.67	0.39	0.51
Interest Cover(x)	19.75	14.37	2.69	-1.45
Total Debt/Mcap(x)	0.1	0.08	0.13	0.24

FINANCIAL RATIOS (STANDALONE) FOR ASTEC LIFESCIENCES LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	33.03	45.83	13.02	-23.96
CEPS(Rs)	46.16	63.39	30.21	-5.44
DPS(Rs)	1.5	1.5	1.5	0
Book NAV/Share(Rs)	157.39	201.91	213.43	187.82
Tax Rate(%)	27.04	25.8	26.77	24.06
Margin Ratios
Core EBITDA Margin(%)	19.94	22.63	12.08	-1.29
EBIT Margin(%)	16.73	19.14	8.81	-7.98
Pre Tax Margin(%)	15.87	17.8	5.52	-13.47
PAT Margin (%)	11.58	13.21	4.04	-10.23
Cash Profit Margin (%)	16.18	18.27	9.38	-2.32
Performance Ratios
ROA(%)	10.35	11.41	2.68	-4.81
ROE(%)	23.35	25.52	6.27	-11.94
ROCE(%)	22.22	22.22	7.75	-4.52
Asset Turnover(x)	0.89	0.86	0.66	0.47
Sales/Fixed Asset(x)	1.9	1.71	1.31	0.85
Working Capital/Sales(x)	74.91	27.96	-22.36	1981.3
Efficiency Ratios
Fixed Capital/Sales(x)	0.52	0.58	0.76	1.18
Receivable days	113.65	123.7	123.9	128.71
Inventory Days	74.22	78.67	139.3	194.99
Payable days	133.72	150.54	167.15	152.35
Valuation Parameters
PER(x)	30.29	38.24	106.21	0
PCE(x)	21.67	27.64	45.76	-195.11
Price/Book(x)	6.36	8.68	6.48	5.65
Yield(%)	0.15	0.09	0.11	0
EV/Net Sales(x)	3.87	5.49	4.86	5.62
EV/Core EBITDA(x)	18	22.56	34.16	-8069.87
EV/EBIT(x)	22.95	28.52	54.87	-70.3
EV/CE(x)	3.16	4.14	3.12	2.99
M Cap / Sales	3.53	5.08	4.31	4.55
Growth Ratio
Net Sales Growth(%)	6.25	21.93	-7.15	-27.06
Core EBITDA Growth(%)	22.69	38.07	-45.73	-100.36
EBIT Growth(%)	26.45	39.23	-57.28	-165.9
PAT Growth(%)	36.28	38.84	-71.59	-284.12
EPS Growth(%)	36.14	38.77	-71.6	-284.08
Financial Stability Ratios
Total Debt/Equity(x)	0.61	0.71	0.82	1.34
Current Ratio(x)	1.02	1.05	0.95	1
Quick Ratio(x)	0.69	0.67	0.39	0.51
Interest Cover(x)	19.51	14.32	2.68	-1.45
Total Debt/Mcap(x)	0.1	0.08	0.13	0.24

SHARE HOLDING PATTERN FOR ASTEC LIFESCIENCES LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	65.29	66.77	66.77	66.77	66.76	66.75	66.75	66.75	66.75	66.75
FII %	0.48	1.53	2.19	2.29	1.95	1.33	1.28	1.25	1.03	0.53
DII %	1.54	1.11	1.12	1.01	1.01	1.01	0.97	0.09	0.33	0.50
Public %	22.45	21.87	21.50	20.37	21.14	21.76	22.23	24.11	28.84	28.21

PEER COMPARISON FOR ASTEC LIFESCIENCES LIMITED

No.	Name
1	BASF India Limited
2	Rallis India Limited
3	Excel Industries Limited
4	Bayer Cropscience Limited
5	Punjab Chemicals & Crop Protection Limited
6	TRANSPEK INDUSTRY LTD
7	Dhanuka Agritech Limited
8	UPL Limited
9	PI Industries Limited
10	AIMCO PESTICIDES LTD
11	NACL Industries Limited
12	Insecticides (India) Limited
13	Bharat Rasayan Limited
14	Sumitomo Chemical India Limited
15	Astec LifeSciences Limited
16	Heranba Industries Limited
17	Best Agrolife Limited
18	India Pesticides Limited

CORPORATE ACTIONS FOR ASTEC LIFESCIENCES

Exchange Date	Purpose	Book Closure Dates
BSE 09-Oct-2024	Board Meeting - Quarterly Results	25-Oct-2024
BSE 18-Jul-2024	Board Meeting - Quarterly Results	29-Jul-2024
BSE 02-May-2024	Book Closure - A.G.M.	24-Jul-2024 28-Jul-2024
BSE 02-May-2024	AGM - A.G.M.	28-Jul-2024 28-Jul-2024
BSE 24-Apr-2024	Board Meeting - Audited Results	02-May-2024
BSE 12-Jan-2024	Board Meeting - Quarterly Results	25-Jan-2024
BSE 10-Oct-2023	Board Meeting - Quarterly Results & Inter alia, may also consider and approve enhancement in the existing limit of issuance of Debenture(s) or Debt Securities upto such limit as may be deemed appropriate by the Board, subject to such other approval(s) as may be applicable.	27-Oct-2023
BSE 20-Jul-2023	Board Meeting - Quarterly Results	27-Jul-2023
BSE 02-May-2023	Book Closure - Rs.1.5000 per share(15%)Final Dividend & A.G.M.	22-Jul-2023 26-Jul-2023
BSE 02-May-2023	AGM - Rs.1.5000 per share(15%)Final Dividend & A.G.M.	27-Jul-2023 26-Jul-2023
BSE 02-May-2023	Dividend - Rs.1.5000 per share(15%)Final Dividend
BSE 21-Apr-2023	Board Meeting - Audited Results & Final Dividend	02-May-2023
BSE 11-Jan-2023	Board Meeting - Quarterly Results	30-Jan-2023
BSE 20-Oct-2022	Board Meeting - Quarterly Results	28-Oct-2022
BSE 18-Jul-2022	Board Meeting - Quarterly Results	25-Jul-2022
BSE 02-May-2022	Book Closure - Rs.1.5000 per share(15%)Final Dividend & A.G.M.	21-Jul-2022 24-Jul-2022
BSE 02-May-2022	AGM - Rs.1.5000 per share(15%)Final Dividend & A.G.M.	25-Jul-2022 24-Jul-2022
BSE 02-May-2022	Dividend - Rs.1.5000 per share(15%)Final Dividend
BSE 25-Apr-2022	Board Meeting - Audited Results & Final Dividend	02-May-2022
BSE 18-Jan-2022	Board Meeting - Quarterly Results	25-Jan-2022
BSE 20-Oct-2021	Board Meeting - Quarterly Results	27-Oct-2021

CORPORATE ANNOUNCEMENTS FOR ASTEC LIFESCIENCES

Exchange Date	Category File	Description
BSE 26-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Kindly find enclosed the copy of the newspaper publication.
BSE 25-Oct-2024	General Announcements FILE	Noting Of Stock Options Lapsed Under Employees Stock Option Plan 2012 (ESOP 2012) Kindly find enclosed intimation regarding Stock Options lapsed on the account of cessation of employment.
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find enclosed Press Release for the Quarter and Half Year ended September 30 2024
BSE 25-Oct-2024	Outcome FILE	Financial Results- September 30 2024 Outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Capitalization Of Herbicide Unit Situated At Mahad Maharashtra Please find enclosed outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Approval Of Material Related Party Transactions To Be Entered During The Financial Year 2024-25 Please find enclosed outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Appointment Of Cost Auditor Please find enclosed outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Resignation Of Cost Auditor Please find enclosed outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Appointment Of Manager Please find enclosed outcome of Board Meeting
BSE 25-Oct-2024	General Announcements FILE	Conduct Of Postal Ballot For Certain Matters Please find attached outcome of the Board Meeting
BSE 25-Oct-2024	Outcome FILE	Outcome Of The Board Meeting Dated October 25 2024 Please find enclosed outcome of the Board Meeting
BSE 25-Oct-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday October 25 2024 Please find enclosed outcome of the Board Meeting dated October 25 2024
BSE 11-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Kindly find enclosed the disclosure under Regulation 74(5).
BSE 09-Oct-2024	Intimation FILE	Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2024 After These Results Are Reviewed By The Audit Committee. ASTEC LIFESCIENCES LIMITEDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Kindly find enclosed the prior intimation of the Company.
BSE 07-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Cessation Kindly find enclosed the confirmation in respect of the resignation of an Independent Director of the Company.
BSE 04-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Kindly find enclosed the intimation of resignation of an Independent Director of the Company.
BSE 04-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Director Kindly find enclosed the intimation.
BSE 04-Oct-2024	General Announcements FILE	Intimation Of Resignation Of An Independent Director Kindly find enclosed the intimation
BSE 04-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Kindly find enclosed the intimation of resignation of an Independent Director of the Company.
BSE 04-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Cessation Kindly find enclosed the intimation of resignation of an independent Director of the Company.
BSE 27-Sep-2024	Intimation FILE	Closure of Trading Window Kindly find enclosed the intimation of the closure of the trading window of the Company for the Quarter and Half Year ending September 30 2024.
BSE 23-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Director Kindly find enclosed the resignation of Mr. Anurag Roy.
BSE 23-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) Kindly find enclosed the resignation of Mr. Anurag Roy
BSE 23-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Kindly find enclosed the resignation of Whole Time Director & Chief Executive Officer
BSE 23-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Kindly find enclosed the resignation of the Whole Time Director & Chief Executive Officer.
BSE 23-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Cessation Intimation of resignation of Whole Time Director & Chief Executive Officer
BSE 17-Sep-2024	General Announcements FILE	Appointment Of Dr. Ganapati Dadasaheb Yadav As A 'Non-Executive & Independent Director' Of The Company To Hold Office For A Term Commencing From 17Th September 2024 Upto 13Th September 2027 Subject To Approval Of The Shareholders Kindly find enclosed the intimation of appointment of Independent Director of the Company.
BSE 17-Sep-2024	General Announcements FILE	Appointment Of Dr. Ganapati Dadasaheb Yadav As A 'Non-Executive & Independent Director' Of The Company To Hold Office For A Term Commencing From 17Th September 2024 Upto 13Th September 2027 Subject To Approval Of The Shareholders Kindly find enclosed the intimation on appointment of Independent Director of the Company.
BSE 17-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Kindly find enclosed the intimation of appointment of Independent Director.
BSE 04-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Kindly find enclosed the intimation of allotment of ESOP.

INSIDER TRADING FOR ASTEC LIFESCIENCES

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 06-Jun-2023 06-Jun-2023	Sell Market	3,390 @ 0.00 (0.00 %)	Balram Singh Yadav
BSE 01-Aug-2022 01-Aug-2022	Buy Market	13,651 @ 0.00 (0.07 %)	GODREJ AGROVET LTD
BSE 02-Aug-2022 02-Aug-2022	Buy Market	3,943 @ 0.00 (0.02 %)	GODREJ AGROVET LTD
BSE 03-Aug-2022 03-Aug-2022	Buy Market	949 @ 0.00 (0.01 %)	GODREJ AGROVET LTD
BSE 29-Jul-2022 29-Jul-2022	Buy Market	117,161 @ 0.00 (0.59 %)	GODREJ AGROVET LTD
BSE 28-Jul-2022 28-Jul-2022	Buy Market	59,298 @ 0.00 (0.31 %)	GODREJ AGROVET LTD
BSE 28-Mar-2022 28-Mar-2022	Buy Market	1,727 @ 0.00 (0.00 %)	ASHOK HIREMATH
BSE 24-Mar-2022 24-Mar-2022	Buy Market	18,453 @ 0.00 (0.09 %)	ASHOK V HIREMATH
BSE 25-Mar-2022 25-Mar-2022	Buy Market	3,108 @ 0.00 (0.02 %)	ASHOK V HIREMATH
BSE 10-Mar-2022 10-Mar-2022	Buy Market	600 @ 0.00 (0.00 %)	Sandeep Kumar Singh
BSE 07-Mar-2022 07-Mar-2022	Buy Market	1,000 @ 0.00 (0.01 %)	Balram Singh Yadav
BSE 28-Feb-2022 28-Feb-2022	Buy Market	2,390 @ 0.00 (0.00 %)	BALRAM S YADAV
BSE 15-Dec-2021 15-Dec-2021	Sell Market	1,000 @ 0.00 (0.00 %)	Ramesh Pingale
BSE 13-Dec-2021 13-Dec-2021	Sell Market	1,000 @ 0.00 (0.01 %)	Ramesh Pingale
BSE 15-Nov-2021 15-Nov-2021	Sell Market	1,710 @ 0.00 (0.01 %)	Ramesh Pingale

BULK BLOCK DEALS FOR ASTEC LIFESCIENCES LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
No Bulk Block details found

DIVIDEND BY ASTEC LIFESCIENCES LIMITED

Ex Dividend Date	Dividend Type	Dividend
21-Jul-2023	DIVIDEND	1.5
19-Jul-2022	DIVIDEND	1.5
22-Jul-2021	DIVIDEND	1.5

SPLIT / BONUS BY ASTEC LIFESCIENCES LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Astec LifeSciences Limited

Astec LifeSciences share price

CONSOLIDATED QUARTERLY RESULT FOR ASTEC LIFESCIENCES LIMITED

STANDALONE QUARTERLY RESULT FOR ASTEC LIFESCIENCES LIMITED

CONSOLIDATED ANNUAL RESULT FOR ASTEC LIFESCIENCES LIMITED

STANDALONE ANNUAL RESULT FOR ASTEC LIFESCIENCES LIMITED

CONSOLIDATED PROFIT / LOSS FOR ASTEC LIFESCIENCES LIMITED

STANDALONE PROFIT / LOSS FOR ASTEC LIFESCIENCES LIMITED

CONSOLIDATED CASH FLOW FOR ASTEC LIFESCIENCES LIMITED

STANDALONE CASH FLOW FOR ASTEC LIFESCIENCES LIMITED

CONSOLIDATED BALANCE SHEET FOR ASTEC LIFESCIENCES LIMITED

STANDALONE BALANCE SHEET FOR ASTEC LIFESCIENCES LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR ASTEC LIFESCIENCES LIMITED

FINANCIAL RATIOS (STANDALONE) FOR ASTEC LIFESCIENCES LIMITED

SHARE HOLDING PATTERN FOR ASTEC LIFESCIENCES LIMITED

PEER COMPARISON FOR ASTEC LIFESCIENCES LIMITED

CORPORATE ACTIONS FOR ASTEC LIFESCIENCES

CORPORATE ANNOUNCEMENTS FOR ASTEC LIFESCIENCES

INSIDER TRADING FOR ASTEC LIFESCIENCES

BULK BLOCK DEALS FOR ASTEC LIFESCIENCES LIMITED

DIVIDEND BY ASTEC LIFESCIENCES LIMITED

SPLIT / BONUS BY ASTEC LIFESCIENCES LIMITED